A recent analysis reveals that the incidence rates of soft tissue sarcomas - cancers in muscle, fat, blood vessels, nerves, and tendons - are lower in young U.S. active-duty military servicemen ...
Hosted on MSN
Soft Tissue Sarcoma: Causes, Symptoms and Treatments
Soft Tissue Sarcoma: Causes, Symptoms and Treatments: By Shreoshree Chakrabarty Soft tissue sarcoma is a rare form of cancer that can arise in various tissues of the body, including muscles, fat, ...
The National Comprehensive Cancer Network ® (NCCN ®) today published new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for Pediatric Soft Tissue Sarcomas. This is the 7th NCCN ...
Angiosarcoma is an aggressive malignancy derived from endothelial cells, characterised by its rapid progression, heterogeneity and distinct clinical challenges. As a subset of soft tissue sarcomas, ...
Sarcoma originates in connective tissues, with soft tissue and bone sarcomas as primary categories, each having multiple subtypes. Staging considers tumor size, grade, and metastasis, guiding ...
Please provide your email address to receive an email when new articles are posted on . The addition of pembrolizumab to radiation and surgery reduced relapse risk by 43%. Results showed no ...
CLD-201, an allogeneic adipose stem-cell loaded oncolytic virus, received FDA fast track designation for soft tissue sarcoma treatment. Fast track designation expedites drug development and review for ...
The National Comprehensive Cancer Network (NCCN) published new guidelines for pediatric soft tissue sarcoma (STS), growing the NCCN’s library of guidelines to now cover 91 topics in cancer care. 1 ...
Early results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center and Stanford Medicine suggest that combining targeted radiation ...
Determining the recommended phase 2 dose (RP2D) of dose-intense irinotecan combined with IVA chemotherapy (IRIVA) in newly diagnosed very high risk rhabdomyosarcoma: A phase Ib study within the EpSSG ...
Canine soft tissue sarcomas (STS) constitute a heterogeneous group of mesenchymal tumours that present diverse morphological and clinical profiles. These neoplasms commonly affect the skin and ...
Comprehensive molecular analysis of phase IB/II trial of durvalumab plus doxorubicin combination in patients with advanced soft-tissue sarcoma. Change in T2-weighted signal intensity, change in tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results